Business
Nanox to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 31, 2025
PETACH TIKVA, Israel, March 17, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter and fiscal year ended December 31, 2024, before market open on Monday, March 31, 2025. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a busin
About this update from Nano-x Imaging Ltd
[{"type":"image","alt":"Nano-X Imaging LTD.","displaySize":"","headline":null,"caption":"Nano-X Imaging LTD.","className":"","disableSlideshowImg":false,"size":{"original":{"width":250,"height":64,"url":"https://media.zenfs.com/en/globenewswire.com/bb68e1b6e7ee0b6ba64825d135e6c05a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/13ZFHOV0PmhW0sUP.nWsmQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwODtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/bb68e1b6e7ee0b6ba64825d135e6c05a","width":250,"height":64}},"lazy":false},{"type":"text","content":"PETACH TIKVA, Israel, March 17, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter and fiscal year ended December 31, 2024, before market open on Monday, March 31, 2025. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET.","length":567,"tagName":"p"},{"type":"text","content":"Interested parties may register for the conference call using the following link: Nanox Q4 Earnings Call Registration. The live webcast of the conference call may be accessed by using the following link: Nanox Q4 Earnings Webcast. The link will also be posted in the Investor Relations section of the Nanox website at Events and Presentations.","length":358,"tagName":"p"},{"type":"text","content":"About Nanox","length":11,"tagName":"p"},{"type":"text","content":"Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by bringing a full solution of affordable medical imaging technologies based on advanced AI and proprietary digital X-ray source.","length":221,"tagName":"p"},{"type":"text","content":"Nanox's vision encompasses expanding the reach of Nanox technology both within and beyond hospital settings, providing a seamless end-to-end solution from scan to diagnosis, leveraging AI for more accurate diagnostics and maintaining a clinically driven approach. The Nanox ecosystem includes Nanox.ARC – a multi-source digital tomosynthesis system that is cost-effective and user-friendly; Nanox.AI LTD, a subsidiary of Nanox Imaging, is an AI-based suite o...